1.Comparison of CT-Guided Sclerotherapy with Using 95% Ethanol and 20% Hypertonic Saline for Managing Simple Renal Cyst.
Hulusi EGILMEZ ; Vedat GOK ; Ibrahim OZTOPRAK ; Mehmet ATALAR ; Ali CETIN ; Mubeccel ARSLAN ; Yener GULTEKIN ; Orhan SOLAK
Korean Journal of Radiology 2007;8(6):512-519
OBJECTIVE: We wanted to compare the efficacies of 95% ethanol and 20% hypertonic saline (HS) sclerotherapies that were performed in a single session under CT guidance for the management of simple renal cysts. MATERIALS AND METHODS: A prospective series of 74 consecutive patients (average age: 57.6 +/- 8.1 years) with simple renal cysts were enrolled in this study. They were randomized into two groups and 95% ethanol or 20% HS, respectively, corresponding to 25% of the aspiration volume, was injected. Treatment success was determined six months later with follow-up clinical evaluation and performing ultrasonography. RESULTS: The sclerotherapy was accepted as technically successful without major complications in all except two patients who were excluded because of a communication between the simple renal cyst and the pelvicalyceal collecting system. Thirty-six patients in the ethanol group received sclerotherapy with 95% ethanol and 36 patients in the HS group underwent sclerotherapy with 20% HS. The complete regression ratio of the ethanol group was significantly higher (94% versus 72%, respectively) than that of the HS group. There was one patient with partial regression in each group. The failure ratio of the ethanol group was significantly lower (3% versus 25%, respectively) than that of the HS group. CONCLUSION: Ethanol sclerotherapy under CT guidance is a successful and safe procedure and it can be used for the treatment of simple renal cysts. Sclerotherapy with 95% ethanol is more effective than 20% HS sclerotherapy. Sclerotherapy with HS may be an option for patients preferring to undergo a less painful treatment procedure.
Adult
;
Aged
;
Ethanol/administration & dosage/*therapeutic use
;
Female
;
Follow-Up Studies
;
Humans
;
Kidney/drug effects/radiography/ultrasonography
;
Kidney Diseases, Cystic/*drug therapy
;
Male
;
Middle Aged
;
Prospective Studies
;
Saline Solution, Hypertonic/administration & dosage
;
Sclerosing Solutions/administration & dosage/*therapeutic use
;
Sclerotherapy/adverse effects/*methods
;
Tomography, X-Ray Computed/*methods
;
Treatment Outcome